Apotex supports launch of home-based cancer care with $1.5M donation
Oct 8, 2025Apotex is helping bring oncology care directly into patients' homes through a $1.5 million donation to Sunnybrook Foundation. The contribution supports the launch of Cancer Care at Home, a new initiative under the Odette Cancer Program that delivers timely cancer care where patients live.
Cancer Care at Home combines remote monitoring, urgent oncology support and hospital-to-home services to create a seamless care pathway. The program aims to reduce emergency visits, ease transitions after hospital stays and provide guidance between appointments.
"Apotex is excited to support the launch of this innovative program that puts patients at the center and allows them to receive care where they are most comfortable," says Allan Oberman, President and CEO of Apotex. "Our team is committed to supporting those on their journey of health and enabling care at home. Patients and their families will truly benefit from this program and we are honoured to partner with Sunnybrook to make it possible."
This initiative reflects Apotex's commitment to expanding access to patient-centred care and supporting healthier communities. It also reinforces our role as a trusted partner in advancing innovative healthcare solutions.
Learn more about Cancer Care at Home and read the full press release here.
Media inquries
Have a question for our media team? Fill out our inquiries form, and we’ll get back to you as soon as possible.
Latest news
-
Nov 17, 2026
Apotex launches APO-LINAGLIPTIN™, expanding access to treatment options for Canadians living with type 2 diabetes
TORONTO, ON, November 16, 2026 – Apotex Health Corp. ("Apotex" or the "Company") (TSX: APTX), the largest Canadian-based global health company, today announced the launch of APO-LINAGLIPTIN™ (linagliptin tablets), the latest addition to its portfolio of medicines.
-
Nov 12, 2026
Apotex Announces Second Quarter 2027 Results
TORONTO, ON, November 12, 2026 – Apotex Health Corp. ("Apotex" or the "Company") (TSX: APTX), a Canadian-based global health company and Canada’s largest pharmaceutical company, today announced its financial and operating results for the three and six months ended September 30, 2026. All financial figures are in Canadian dollars unless otherwise indicated.
-
Oct 9, 2026
Apotex to announce second quarter fiscal 2027 financial results and host conference call on Nov. 12, 2026
TORONTO, Oct. 8, 2026 /CNW/ -- Apotex Health Corp.("Apotex") (TSX: APTX) today announced that it will issue a press release with its second quarter Fiscal 2027 financial results on Thursday, November 12, 2026, at approximately 6:00 a.m. ET. Apotex will host a conference call and live webcast to discuss the results at 8:00a.m. ET.